the drug treats diabetic macular oedema -lrb- dmo -rrb- , which affects around 50,000 britons eyesight causing problems with reading , driving and recognising faces .
the rationing body nice has finally given the go ahead for lucentis after the makers dropped the price .
the national institute for health and clinical excellence -lrb- nice -rrb- last year said the drug was not ` a good use of nhs resources ' at # 750 for each monthly injection .
four uk charities failed in their appeal to stop the proposed ban , but nice re-visited the decision after makers novartis cut the price by an undisclosed amount .